Literature DB >> 7930844

Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy.

J Johansen1, S M Bentzen, J Overgaard, M Overgaard.   

Abstract

A colony-forming assay of human skin fibroblast radiosensitivity was established in our laboratory and applied to primary skin biopsies from 12 women belonging to an unselected group of patients who received postmastectomy radiotherapy 10-12 years prior to this study. The aim was to investigate the relationship between in vitro radiosensitivity and the occurrence of subcutaneous fibrosis after radiotherapy. Early generations of normal skin fibroblasts in exponential growth were irradiated at room temperature at a high dose-rate to estimate the surviving fraction of colony-forming cells after single doses ranging from 1 to 8 Gy. A linear-quadratic cell survival curve was fitted to the data and from these fits the surviving fraction at 3.5 Gy (SF3.5) was estimated. Replicate experiments of different cell generations were made to validate the assay, and the between-patients variability was significantly larger than the assay variability for both SF2(p = 0.002) and SF3.5 (p = 0.04). Patients were treated in the period 1978-1982 with a dose per fraction between 2.7 and 3.9 Gy, a total of 12 fractions at two fractions per week. They were evaluated with respect to the occurrence of marked subcutaneous fibrosis in a total of 36 independent treatment fields. In each treatment field the total dose and dose per fraction at the relevant dosimetric reference depth as well as the length of follow-up were recorded. A previously derived LQ mixture model was applied to these data in order to determine the probability of marked fibrosis in that particular field. From this probability and the actually observed fibrosis, the excess risk of fibrosis was calculated, and this was averaged over the three treatment fields to obtain a single measure of clinical radiosensitivity. Increasing values of SF3.5 were statistically significantly correlated with decreasing probabilities of developing subcutaneous fibrosis (p = 0.014, Spearman's rank correlation test). Thus, this pilot study has demonstrated a positive correlation between in vivo radiosensitivity and normal skin fibroblasts and the clinical expression of subcutaneous fibrosis.

Entities:  

Mesh:

Year:  1994        PMID: 7930844     DOI: 10.1080/09553009414551361

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  14 in total

Review 1.  Genetic and epigenetic features in radiation sensitivity. Part II: implications for clinical practice and radiation protection.

Authors:  Michel H Bourguignon; Pablo A Gisone; Maria R Perez; Severino Michelin; Diana Dubner; Marina Di Giorgio; Edgardo D Carosella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

Review 2.  Predicting outcomes in radiation oncology--multifactorial decision support systems.

Authors:  Philippe Lambin; Ruud G P M van Stiphout; Maud H W Starmans; Emmanuel Rios-Velazquez; Georgi Nalbantov; Hugo J W L Aerts; Erik Roelofs; Wouter van Elmpt; Paul C Boutros; Pierluigi Granone; Vincenzo Valentini; Adrian C Begg; Dirk De Ruysscher; Andre Dekker
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

3.  Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016.

Authors:  Deborah E Citrin; Pataje G S Prasanna; Amanda J Walker; Michael L Freeman; Iris Eke; Mary Helen Barcellos-Hoff; Molykutty J Arankalayil; Eric P Cohen; Ruth C Wilkins; Mansoor M Ahmed; Mitchell S Anscher; Benjamin Movsas; Jeffrey C Buchsbaum; Marc S Mendonca; Thomas A Wynn; C Norman Coleman
Journal:  Radiat Res       Date:  2017-05-10       Impact factor: 2.841

4.  Prospective study validating inter- and intraobserver variability of tissue compliance meter in breast tissue of healthy volunteers: potential implications for patients with radiation-induced fibrosis of the breast.

Authors:  A Gabriella Wernicke; Bhupesh Parashar; Fridon Kulidzhanov; Lillian Riley; Paul J Christos; Andrew Fischer; Dattatreyudu Nori; K S Clifford Chao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-13       Impact factor: 7.038

Review 5.  Defining molecular and cellular responses after low and high linear energy transfer radiations to develop biomarkers of carcinogenic risk or therapeutic outcome.

Authors:  Michael Story; Liang-hao Ding; William A Brock; K Kian Ang; Ghazi Alsbeih; John Minna; Seongmi Park; Amit Das
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

6.  Studies of the in vivo radiosensitivity of human skin fibroblasts.

Authors:  Richard P Hill; Pavel Kaspler; Anthony M Griffin; Brian O'Sullivan; Charles Catton; Hamideh Alasti; Ahmar Abbas; Moustafa Heydarian; Peter Ferguson; Jay S Wunder; Robert S Bell
Journal:  Radiother Oncol       Date:  2007-06-27       Impact factor: 6.280

Review 7.  Gene expression arrays as a tool to unravel mechanisms of normal tissue radiation injury and prediction of response.

Authors:  Jacqueline J C M Kruse; Fiona A Stewart
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

Review 8.  Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?

Authors:  Carsten Herskind; Christopher J Talbot; Sarah L Kerns; Marlon R Veldwijk; Barry S Rosenstein; Catharine M L West
Journal:  Cancer Lett       Date:  2016-03-02       Impact factor: 8.679

9.  Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.

Authors:  J Dunst; S Neubauer; A Becker; E Gebhart
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

10.  Oral pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study.

Authors:  Nicole L Simone; Benjamin P Soule; Lynn Gerber; Elizabeth Augustine; Sharon Smith; Rosemary M Altemus; James B Mitchell; Kevin A Camphausen
Journal:  Radiat Oncol       Date:  2007-05-31       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.